KLAR Klaria Pharma Holding AB (publ.)

0.0511USD0.5190 SEK · STO+0.19%Mkt Cap: 12.57M USDP/E: —

Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock. Its product pipeline includes Sumatripta…

Key Statistics

Company
Market Cap12.57M USD
Enterprise Value11.73M USD
Revenue (TTM)9.84K USD
Gross Profit9.84K USD
Net Income (TTM)-4.63M USD
Revenue/Share0.00 USD
Last Price0.0511 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0007280326
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.15
EV/Revenue1191.96
P/S1276.62
P/B-3.79
EPS (TTM)-0.02 USD
EPS (Forward)0.00 USD
52W Range
0.04438% of range0.1309
52W High0.1309 USD
52W Low0.0443 USD
Profitability
Gross Margin100.00%
Oper. Margin-39872.00%
EBITDA Margin0.00%
Profit Margin-523.75%
ROE390.69%
ROA-144.65%
ROIC-265.46%
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.37M USD
CapEx (TTM)—
FCF Margin-26969.75%
FCF Yield-21.13%
Net Debt-833.50K USD
Net Debt/EBITDA0.29
Net Debt/FCF—
Balance Sheet
Debt/Equity-2.08
Current Ratio0.20
Quick Ratio0.20
Book Value/Sh-0.01 USD
Cash/Share0.0033 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.245.98M
Float241.34M
Insiders16.77%
Institutions32.90%
Technical
SMA 500.0542 (-5.7%)
SMA 2000.0762 (-33.0%)
Beta1.31
S&P 52W Chg12.00%
Avg Vol (30d)863.18K
Avg Vol (10d)435.09K
Technical Indicators
RSI (14)46.6
MACD-0.0145
MACD Signal-0.0174
MACD Hist.+0.0029
BB Upper0.0548 USD
BB Middle0.0513 USD
BB Lower0.0478 USD
BB Width13.63%
ATR (14)0.0035 USD
Vol Ratio (20d)1.56x

About Klaria Pharma Holding (STO: KLAR)

›

Klaria Pharma Holding (STO: KLAR) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 4 employees.

The shares were at 0.5190 SEK on 19 November 2026, up 8.6% over 52 weeks. Its 52-week range is 0.4500 SEK to 1.330 SEK: the price is 61.0% below the high and 15.3% above the low.

Its market capitalisation is 127.66M SEK.

Klaria Pharma Holding reports return on equity of 390.7%.

It holds more cash than debt, a net cash position of 8.47M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.